MOPH

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01CE02	IRINOTECAN THYMOORGAN	G	Irinotecan HCl - 40mg/2ml	40mg/2ml	Injectable concentrated solution	L.L
L01DB01	DOXORUBICINE EBEWE	G	Doxorubicin HCl - 2mg/ml	50mg/25ml	Injectable concentrated solution	L.L
N03AF01	TEGRETOL	B	Carbamazepine - 2%	2%	Suspension	L.L
L04AA06	MYFORTIC	B	Mycophenolic acid (sodium) - 360mg	360mg	Tablet, gastroresistant	L.L
L01CD02	DOCETAXEL EBEWE	G	Docetaxel - 80mg/8ml	80mg/8ml	Injectable solution	L.L
L01BC01	ALEXAN	G	Cytarabine - 1,000mg/20ml	1,000mg/20ml	Injectable solution	L.L
L01CA04	EBERELBIN	G	Vinorelbine (tartrate) - 50mg/5ml	50mg/5ml	Injectable concentrated solution	L.L
L01XA03	OXALIPLATIN EBEWE	G	Oxaliplatin - 50mg/10ml	50mg/10ml	Injectable concentrated solution	L.L
L01CE02	IRINOTECAN GP PHARM	G	Irinotecan HCl trihydrate - 100mg/5ml	100mg/5ml	Injectable concentrated solution	L.L
L04AX04	LENALIDOMIDE NEAPOLIS	G	Lenalidomide - 10mg	10mg	Capsule	L.L
L04AX04	LENALIDOMIDE NEAPOLIS	G	Lenalidomide - 15mg	15mg	Capsule	L.L
L04AC05	USTEKIREL	BioTech	Ustekinumab - 90mg	90mg	Injectable solution	L.L
L01XX52	VENCLEXTA	B	Venetoclax - 10mg week 1, Venetoclax - 50mg week 2, Venetoclax - 100mg week 3&4		Tablet	L.L
N05AX13	INVEGA SUSTENNA	B	Paliperidone palmitate - 100mg	100mg	Injectable suspension, prolonged release	L.L
N05AX13	INVEGA SUSTENNA	B	Paliperidone palmitate - 150mg	150mg	Injectable suspension, prolonged release	L.L
N05AX13	TREVICTA	B	Paliperidone - 350mg	350mg	Injectable suspension, prolonged release	L.L
N05AX13	TREVICTA	B	Paliperidone - 525mg	525mg	Injectable suspension, prolonged release	L.L
B06AC05	TAKHZYRO	BioTech	Lanadelumab - 300mg/2ml	300mg	Injectable solution	L.L
J05AF10	HEPCAVIR 0.5	G	Entecavir monohydrate - 0.5mg	0.5mg	Tablet, film coated	L.L
J05AF10	HEPCAVIR 1	G	Entecavir monohydrate - 1mg	1mg	Tablet, film coated	L.L
B02BD02	BERIATE	BioHuman	Coagulation Factor VIII - 500IU	500IU	Injectable lyophilised powder for solution+diluent	L.L